⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GSK News
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
globenewswire.com
EBS
GSK
MRK
MRNA
NVAX
PFE
Unlocking Opportunity: Dominate the Cancer Vaccine Market with Confidence Now Available. Tracks 960+ Organizations and 2,100+ Drugs Across the Full Cancer Vaccine Pipeline
globenewswire.com
INO
BNTX
GSK
Asthma and COPD Drugs Market to Grow from USD 33.16 Billion in 2025 to USD 56.21 Billion by 2035, at a CAGR of 5.42% - SNS Insider
globenewswire.com
AZN
PFE
GSK
NVS
Sitryx to Participate in Upcoming Investor Conferences
globenewswire.com
LLY
GSK
Breast Cancer Therapeutics Market Size to Reach USD 95.14 Billion at a CAGR of 9.20% from 2035 – SNS Insider
globenewswire.com
PFE
LLY
MRK
GILD
ABBV
BMY
AMGN
PBYI
GSK
TEVA
EXEL
Global Topical Drug Delivery Market to Reach $362.3 Billion by 2031, Driven by Rising Prevalence of Skin Disorders and Innovation in Non-Invasive Delivery Technologies
globenewswire.com
ABBV
ALM
BHC
GILD
GSK
SNY
SOLV
TEVA
The International Myeloma Foundation Wants You to #KnowMyeloma for Blood Cancer Awareness Month 2026
globenewswire.com
BMY
GSK
U.S. FDA approves ViiV Healthcare’s Tivicay PD, helping close a critical HIV treatment gap for young children
businesswire.com
GSK
Vivace Therapeutics Strengthens Leadership Team as It Prepares to Advance VT3989, the First TEAD Inhibitor to enter Phase 3 Clinical Trials, as the Leading Treatment for Mesothelioma
prnewswire.com
GILD
GSK
Blood Cancer Therapeutics Market to Reach $125.5 Billion by 2030, Driven by Precision Medicine Advances and Expanding Immunotherapy Pipelines
globenewswire.com
ABBV
AMGN
AZN
BMY
ROG
GILD
GSK
JNJ
LLY
MRK
NVS
SNY
PFE
JAZZ
AMRX